Victory Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503K | Sell |
4,823
-10
| -0.2% | -$1.04K | ﹤0.01% | 2059 |
|
|
2025
Q1 | $564K | Sell |
4,833
-67
| -1% | -$7.81K | ﹤0.01% | 1999 |
|
|
2024
Q4 | $415K | Sell |
4,900
-60
| -1% | -$5.08K | ﹤0.01% | 2075 |
|
|
2024
Q3 | $446K | Sell |
4,960
-75
| -1% | -$6.74K | ﹤0.01% | 2041 |
|
|
2024
Q2 | $405K | Sell |
5,035
-71
| -1% | -$5.72K | ﹤0.01% | 2028 |
|
|
2024
Q1 | $407K | Sell |
5,106
-102
| -2% | -$8.14K | ﹤0.01% | 2044 |
|
|
2023
Q4 | $415K | Sell |
5,208
-13,726
| -72% | -$1.09M | ﹤0.01% | 2044 |
|
|
2023
Q3 | $1.32M | Buy |
18,934
+15,176
| +404% | +$1.06M | ﹤0.01% | 1526 |
|
|
2023
Q2 | $270K | Sell |
3,758
-86
| -2% | -$6.18K | ﹤0.01% | 2138 |
|
|
2023
Q1 | $237K | Buy |
3,844
+185
| +5% | +$11.4K | ﹤0.01% | 2207 |
|
|
2022
Q4 | $282K | Buy |
+3,659
| New | +$282K | ﹤0.01% | 2187 |
|
|
2021
Q3 | – | Sell |
-4,441
| Closed | -$300K | – | 2781 |
|
|
2021
Q2 | $300K | Sell |
4,441
-117
| -3% | -$7.9K | ﹤0.01% | 2412 |
|
|
2021
Q1 | $258K | Sell |
4,558
-2,541
| -36% | -$144K | ﹤0.01% | 2452 |
|
|
2020
Q4 | $578K | Sell |
7,099
-1,598
| -18% | -$130K | ﹤0.01% | 2008 |
|
|
2020
Q3 | $620K | Buy |
8,697
+928
| +12% | +$66.2K | ﹤0.01% | 1884 |
|
|
2020
Q2 | $639K | Sell |
7,769
-14,651
| -65% | -$1.21M | ﹤0.01% | 1903 |
|
|
2020
Q1 | $1.32M | Buy |
22,420
+8,733
| +64% | +$513K | ﹤0.01% | 1754 |
|
|
2019
Q4 | $1.42M | Buy |
13,687
+4,665
| +52% | +$482K | ﹤0.01% | 1640 |
|
|
2019
Q3 | $183K | Buy |
+9,022
| New | +$183K | ﹤0.01% | 2246 |
|